2019 - 2026 A single-cell atlas of lung adenocarcinoma and adjacent normal-appearing tissu
2020 - 2025 SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
2018 - 2023 The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
2018 - 2023 The Lung PCA; A Multi-Dimensional Atlas of Pulmonary Premalignancy
2019 - 2023 Detection of Early Lung Cancer Among Military Personnel
2019 - 2023 Detection of Early Lung Cancer Among Military Personnel (DECAMP-1 Plus)
2017 - 2022 Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
2017 - 2022 Detection of Early Lung Cancer Among Military Personnel (DECAMP)
2018 - 2021 Circulating Exosomes as Biomarkers for Lung Cancer Early Detection
2001 - 2001 胃癌におけるテロメアDNA結合蛋白の発現とその生物学的意義
全件表示
論文 (164件):
Hoi-Hin Kwok, Huiyu Li, Jiashuang Yang, Junyang Deng, Nerissa Chui-Mei Lee, Timmy Wing-Kuk Au, Alva Ko-Yung Sit, Michael Kuan-Yew Hsin, Stephanie Kwai-Yee Ma, Lydia Wai-Ting Cheung, et al. Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma. Cancer communications (London, England). 2023
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter, Myrna C B Godoy, Hope Feldman, William N William Jr, Yuanxin Xi, Sreyashi Basu, et al. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nature medicine. 2023. 29. 3. 593-604
Shidan Wang, Ruichen Rong, Donghan M Yang, Junya Fujimoto, Justin A Bishop, Shirley Yan, Ling Cai, Carmen Behrens, Lynne D Berry, Clare Wilhelm, et al. Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer. The Journal of clinical investigation. 2023. 133. 2
Kenneth E Huffman, Long Shan Li, Ryan Carstens, Hyunsil Park, Luc Girard, Kimberley Avila, Shuguang Wei, Rahul Kollipara, Brenda Timmons, Jessica Sudderth, et al. Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers. Frontiers in oncology. 2023. 13. 1025443-1025443
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, Santhoshi N Krishnan, Priyam Das, Runzhe Chen, Kelly Quek, Jun Li, Edwin R Parra, Luisa M Solis, et al. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2023. 36. 1. 100028-100028
Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, et al. Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma. CANCER RESEARCH. 2021. 81. 13
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick Brennan, Minghao Dang, Dapeng Hao, Ruiping Wang, Enyu Dai, Hitoshi Dejima, et al. Resolving the spatial and cellular architecture of lung adenocarcinoma by multi-region single-cell sequencing. CANCER RESEARCH. 2021. 81. 13
K. Quek, J. Li, J. Fujimoto, J. Zhang, C. -W. Chow, C. Behrens, J. Zhang, A. Weissferdt, S. Swisher, J. J. Lee, et al. Intratumor Heterogeneity Is Associated with Survival of Patients with Stage IA Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 8. S1539-S1539
A. Reuben, R. Gittelman, J. Zhang, C. -J. Wu, J. Zhang, J. Fujimoto, J. Rodriguez-Canales, S. Swisher, J. V. Heymach, H. Robins, et al. TCR Repertoire of Lung Cancer: An Association with Tumor Molecular and Clinicopathological Features. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 8. S1539-S1539
S. Sivakumar, F. A. San Lucas, T. L. McDowell, W. Lang, L. Xu, J. Fujimoto, J. Zhang, I. I. Wistuba, F. A. Futreal, J. Fukuoka, et al. Genomic Landscape of Atypical Adenomatous Hyperplasia and Their Progression to Lung Adenocarcinomas. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 8. S1546-S1546